Advancing the estrous cycle of mares is an essential breeding strategy that is routinely conducted by Thoroughbred breeders to improve economic outcomes. For this purpose, Equilume light masks have been developed as an alternative to existing technologies such as artificial lighting or hormonal treatments because they are considered as valid as existing methods with additional animal welfare advantages. For example, with the Equilume light masks, horses can be let out into the pasture, whereas they have to be kept indoors during lighting treatment. Because the function of Equilume light mask on the estrous cycle of mares is influenced by environmental factors such as nutrition condition and temperature, Equilume light mask should be studied in various environments. The objective of the present study was thus to verify the effect of Equilume light masks on the onset of the estrous cycle in Thoroughbred mares in South Korea. Mares were randomly selected and separated into two groups at two Thoroughbred horse breeding farms. The mares in the treatment group were equipped with Equilume light masks from November 18 to February 10 the following year. The body condition, the number and size (> 35 mm) of uterine follicles, and the uterine horn score of the mares were assessed on January 6 and February 10. The body condition scores were not different between the two groups. The treatment with the Equilume light mask had no positive effects on developing follicles and the reproductive tract. In conclusion, the use of Equilume light masks did not influence the seasonal resumption of the estrus cycles in Thoroughbred mares in South Korea.

Equine reproductive failures for many different reasons are the main contributors to economic losses in the horse industry. This paper describes major bacterial agents isolated from thoroughbred mares that had reproductive failures in the previous year as well as the antimicrobial susceptibility of these bacterial isolates. A total of 146 vaginal and uterine swab samples were submitted to Jeju Self-Governing Veterinary Research Institute by equine veterinarians from 2011 to 2015. Streptococcus equi subspecies zooepidemicus were the most frequently encountered bacteria in 29 samples (48.3%). Other identified species included 21 samples (35%) with Escherichia coli, six samples (10%) with Klebsiella pneumoniae, and four samples (6.7%) with Pseudomonas aeruginosa. All Streptococcus equi subsp. zooepidemicus isolates were sensitive to amoxicillin-clavulanic acid, cefazolin, cefuroxime, and florfenicol, while all were resistant to tetracycline and kanamycin. All E. coli were sensitive to enrofloxacin, ciprofloxacin, and sulfamethoxazole-trimethoprim, and most were susceptible to cefazolin, amoxicillin-clavulanic acid, cefuroxime, florfenicol, and gentamicin. All K. pneumoniae isolates were sensitive to amoxicillin-clavulanic acid, cefazolin, cefuroxime, florfenicol, and ciprofloxacin, while all were resistant to sulfamethoxazole-trimethoprim. P. aeruginosa exhibited sensitivity to quinolones and aminoglycosides, particularly gentamicin, while all were resistant to cefazolin and cefuroxime.

The object of this study was to evaluate Japanese encephalitis virus (JEV) antibody titer changes in broodmares and foals. Antibodies of 112 sera were detected by applying hemagglutination inhibition test. To the best of our knowledge, this is the first report that compares antibody titers of foals to that of their dams in order for evaluate optimal time of JEV vaccination. Most mares` antibody titers were variable. However, the highest titers in foals presented in their first month, and antibodies titers in all foals decreased gradually over time. This study provides important benchmarks that can be used to select optimum time JEV of vaccination.

본 연구는 경주마 생산 육성에 중요한 종빈마의 패독과 방목지에 있어 군별 및 개체별 행동양식을 조사하여 경주마 사양관리의 기초자료로 활용하기 위해 실시하였다. 방목 중인 포유 종빈마군에서는 채식이 62%, 기립 휴식이 31%, 음수가 3%, 횡와 휴식이 1%, 보행이 1%, 수유 행동은 2%가 발현되었는데 러닝은 발현되지 않았다. 포유 종빈마 개체별(3필) 행동발현비율의 평균은 채식이 295분으로 55%, 기립 휴식이 193분으로 36%, 보행과 음수가

더러브렛종 암말의 번식 능력을 향상시키기 위해 호르몬 투여 및 인공 조명에 의한 인위적으로 발정 조절을 실시한 결과는 다음과 같다. 발정 주기에 있는 암말의 또는 altrenogst투여에 의한 발정 발현율은 100%이었으며, 수태율은 각각 95.2% 및 71.4%였다. 전년도 공태마에 대하여 altrenogest단독 또는 altrenogest과 estradiol 병행 투여시 3월 이내 100% 발정이 발현되었으며, 발정 발현일은 altrenogest 투